3-hydroxy-2(1H)-pyridinone chelating agents
Abstract
Disclosed is a series of improved metal chelating agents, which are highly effective upon both injection and oral administration; several of the most effective are of low toxicity. These chelating agents incorporate within their structure 1-hydroxy-2-pyridinone (1,2-HOPO) and 3-hydroxy-2-pyridinone (3,2-HOPO) moieties with a substituted carbamoyl group ortho to the hydroxy or oxo groups of the hydroxypyridinone ring. The electron-withdrawing carbamoyl group increases the acidity of the hydroxypyridinones. In the metal complexes of said chelating agents, the amide protons form very strong hydrogen bonds with its adjacent HOPO oxygen donor, making these complexes very stable at physiological conditions. The terminal N-substituents provides a certain degree of lipophilicity to said 3,2-HOPO, increasing oral activity. Also disclosed is a method of making the chelating agents and a method of producing a known compound, 3-hydroxy-1-alkyl-2(1H)pyridinone, used as a precursor to the chelating agent, safely and in large quantities.
- Inventors:
-
- Berkeley, CA
- Issue Date:
- Research Org.:
- Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)
- OSTI Identifier:
- 870922
- Patent Number(s):
- 5624901
- Assignee:
- Regents of University of California (Oakland, CA)
- Patent Classifications (CPCs):
-
C - CHEMISTRY C07 - ORGANIC CHEMISTRY C07D - HETEROCYCLIC COMPOUNDS
- DOE Contract Number:
- AC03-76SF00098
- Resource Type:
- Patent
- Country of Publication:
- United States
- Language:
- English
- Subject:
- 3-hydroxy-2; 1h; -pyridinone; chelating; agents; disclosed; series; improved; metal; highly; effective; injection; oral; administration; toxicity; incorporate; structure; 1-hydroxy-2-pyridinone; 2-hopo; 3-hydroxy-2-pyridinone; moieties; substituted; carbamoyl; ortho; hydroxy; oxo; hydroxypyridinone; electron-withdrawing; increases; acidity; hydroxypyridinones; complexes; amide; protons; form; strong; hydrogen; bonds; adjacent; hopo; oxygen; donor; stable; physiological; conditions; terminal; n-substituents; provides; degree; lipophilicity; increasing; activity; method; producing; compound; 3-hydroxy-1-alkyl-2; pyridinone; precursor; agent; safely; quantities; metal chelating; metal complexes; chelating agents; chelating agent; highly effective; metal complex; physiological conditions; agents disclosed; -pyridinone chelating; oral administration; hydrogen bonds; /514/530/999/
Citation Formats
Raymond, Kenneth N, and Xu, Jide. 3-hydroxy-2(1H)-pyridinone chelating agents. United States: N. p., 1997.
Web.
Raymond, Kenneth N, & Xu, Jide. 3-hydroxy-2(1H)-pyridinone chelating agents. United States.
Raymond, Kenneth N, and Xu, Jide. Wed .
"3-hydroxy-2(1H)-pyridinone chelating agents". United States. https://www.osti.gov/servlets/purl/870922.
@article{osti_870922,
title = {3-hydroxy-2(1H)-pyridinone chelating agents},
author = {Raymond, Kenneth N and Xu, Jide},
abstractNote = {Disclosed is a series of improved metal chelating agents, which are highly effective upon both injection and oral administration; several of the most effective are of low toxicity. These chelating agents incorporate within their structure 1-hydroxy-2-pyridinone (1,2-HOPO) and 3-hydroxy-2-pyridinone (3,2-HOPO) moieties with a substituted carbamoyl group ortho to the hydroxy or oxo groups of the hydroxypyridinone ring. The electron-withdrawing carbamoyl group increases the acidity of the hydroxypyridinones. In the metal complexes of said chelating agents, the amide protons form very strong hydrogen bonds with its adjacent HOPO oxygen donor, making these complexes very stable at physiological conditions. The terminal N-substituents provides a certain degree of lipophilicity to said 3,2-HOPO, increasing oral activity. Also disclosed is a method of making the chelating agents and a method of producing a known compound, 3-hydroxy-1-alkyl-2(1H)pyridinone, used as a precursor to the chelating agent, safely and in large quantities.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {1997},
month = {1}
}
Works referenced in this record:
Specific sequestering agents for the actinides. 21. Synthesis and initial biological testing of octadentate mixed catecholate-hydroxypyridinonate ligands
journal, February 1993
- Uhlir, Linda C.; Durbin, Patricia W.; Jeung, Nylan
- Journal of Medicinal Chemistry, Vol. 36, Issue 4, p. 504-509
In Vivo Chelation of Am(III), Pu(IV), Np(V), and U(VI) in Mice by TREN-(Me-3,2-HOPO)
journal, May 1994
- Durbin, P. W.; Kullgren, B.; Xu, J.
- Radiation Protection Dosimetry, Vol. 53, Issue 1-4
Novel 3-hydroxy-2(1H)-pyridinones. Synthesis, iron(III)-chelating properties and biological activity
journal, June 1990
- Streater, Michael; Taylor, Paul D.; Hider, Robert C.
- Journal of Medicinal Chemistry, Vol. 33, Issue 6, p. 1749-1755
Ferric ion sequestering agents. 14. 1-Hydroxy-2(1H)-pyridinone complexes: properties and structure of a novel iron-iron dimer
journal, November 1985
- Scarrow, Robert C.; White, David L.; Raymond, Kenneth N.
- Journal of the American Chemical Society, Vol. 107, Issue 23, p. 6540-6546
Specific Sequestering Agents for the Actinides. 28. Synthesis and Initial Evaluation of Multidentate 4-Carbamoyl-3-hydroxy-1-methyl-2(1H)-pyridinone Ligands for in Vivo Plutonium(IV) Chelation
journal, July 1995
- Xu, Jide; Kullgren, Birgitta; Durbin, Patricia W.
- Journal of Medicinal Chemistry, Vol. 38, Issue 14